Deeper Dive: Understanding Enveric Biosciences Inc (ENVB) Through its Various Ratios

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

The price of Enveric Biosciences Inc (NASDAQ: ENVB) closed at $0.84 in the last session, down -5.55% from day before closing price of $0.89. In other words, the price has decreased by -$5.55 from its previous closing price. On the day, 0.56 million shares were traded. ENVB stock price reached its highest trading level at $0.9072 during the session, while it also had its lowest trading level at $0.84.


We take a closer look at ENVB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.29 and its Current Ratio is at 1.29. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 15 ’23 when PASQUALONE FRANK bought 1,000 shares for $2.14 per share. The transaction valued at 2,140 led to the insider holds 1,000 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENVB now has a Market Capitalization of 6131345 and an Enterprise Value of 3843363.

Stock Price History:

The Beta on a monthly basis for ENVB is 0.84, which has changed by -0.41352856 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, ENVB has reached a high of $6.98, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -20.18%, while the 200-Day Moving Average is calculated to be -45.64%.

Shares Statistics:

According to the various share statistics, ENVB traded on average about 4.67M shares per day over the past 3-months and 2218880 shares per day over the past 10 days. A total of 7.75M shares are outstanding, with a floating share count of 7.60M. Insiders hold about 1.92% of the company’s shares, while institutions hold 6.55% stake in the company. Shares short for ENVB as of 1714435200 were 81222 with a Short Ratio of 0.02, compared to 1711584000 on 254873. Therefore, it implies a Short% of Shares Outstanding of 81222 and a Short% of Float of 1.1199999999999999.

Earnings Estimates

Investors are keenly observing as 2.0 analysts analyze and rate the current performance of Enveric Biosciences Inc (ENVB) in the stock market.On average, analysts expect EPS of -$0.77 for the current quarter, with a high estimate of -$0.61 and a low estimate of -$0.94, while EPS last year was -$2.47. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.52 and low estimates of -$0.55.

Analysts are recommending an EPS of between -$2.08 and -$3.25 for the fiscal current year, implying an average EPS of -$2.66. EPS for the following year is -$1.41, with 1.0 analysts recommending between -$1.41 and -$1.41.

Most Popular

[the_ad id="945"]